Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMQAC4K)

Drug Name	PMID27539678-Compound-7 Drug Info
Cross-matching ID	PubChem CID 67609351 TTD Drug ID DMQAC4K

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Sphingosine kinase 1 (SPHK1)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Phenoxodiol	DMBUJVX	Ovarian cancer	2C73	Phase 1/2	[2]
GSK618334	DMJPXZ4	Drug abuse	6C4G.1Z	Phase 1	[3]
PMID27539678-Compound-6	DMBKNDE	N. A.	N. A.	Patented	[1]
Methylbenzenesulfonamide derivative 1	DMUNME2	N. A.	N. A.	Patented	[1]
PMID27539678-Compound-12	DMNIKTA	N. A.	N. A.	Patented	[1]
PMID27539678-Compound-10	DM61SR0	N. A.	N. A.	Patented	[1]
PMID27539678-Compound-16	DMMDJH8	N. A.	N. A.	Patented	[1]
PMID27539678-Compound-14	DMZ02LA	N. A.	N. A.	Patented	[1]
PMID27539678-Compound-13	DM1J2V8	N. A.	N. A.	Patented	[1]
PMID27539678-Compound-11	DMIKAJC	N. A.	N. A.	Patented	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	Sphingosine kinase inhibitors: a review of patent literature (2006-2015).Expert Opin Ther Pat. 2016 Dec;26(12):1409-1416.
2	Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
3	Sphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.Oncotarget. 2016 Dec 6;7(49):80586-80598.